What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Antibiotics
Paul T. Heath mainly focuses on Pediatrics, Vaccination, Incidence, Immunology and Internal medicine.
His work on Meningitis as part of general Pediatrics study is frequently connected to Streptococcus agalactiae, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Vaccination study incorporates themes from Booster dose, Immunization, Conjugate vaccine, Haemophilus influenzae and Carriage.
Paul T. Heath has included themes like Disease, Disease burden, Serotype and Group B in his Incidence study.
His biological study spans a wide range of topics, including Database research, Hematopoietic stem cell transplantation and Treatment modality.
His Internal medicine research incorporates themes from Gastroenterology, Surgery and Reactogenicity.
His most cited work include:
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
- Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. (416 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pediatrics, Vaccination, Immunology, Incidence and Group B.
His Pediatrics research is multidisciplinary, relying on both Pregnancy, Epidemiology, Disease and Sepsis.
His Vaccination research is multidisciplinary, incorporating elements of Booster dose, Immunization, Conjugate vaccine, Haemophilus influenzae and Internal medicine.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Vaccine efficacy.
His Immunology study frequently involves adjacent topics like Virology.
His research integrates issues of Prospective cohort study, Serotype and Antibiotic prophylaxis in his study of Group B.
He most often published in these fields:
- Pediatrics (44.83%)
- Vaccination (28.74%)
- Immunology (20.40%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (15.52%)
- Pediatrics (44.83%)
- Pregnancy (16.38%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Pediatrics, Pregnancy, Vaccination and Incidence.
The Internal medicine study combines topics in areas such as Antibiotics and Vaccine efficacy.
His Pediatrics study combines topics from a wide range of disciplines, such as Outbreak, Tetanus, Disease and Group B.
His Vaccination research includes elements of Public health and Confidence interval.
His Incidence research includes themes of Carriage, Cross-sectional study, Epidemiology and Meningococcal carriage.
The Adverse effect study combines topics in areas such as Booster dose and Reactogenicity.
Between 2018 and 2021, his most popular works were:
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. (90 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Antibiotics
Paul T. Heath focuses on Internal medicine, Adverse effect, Vaccination, Vaccine efficacy and Pregnancy.
His research investigates the connection between Internal medicine and topics such as Antibiotics that intersect with problems in Hospital-acquired infection and Drug resistance.
Within one scientific family, Paul T. Heath focuses on topics pertaining to Randomized controlled trial under Adverse effect, and may sometimes address concerns connected to Clinical trial.
His work in Vaccination covers topics such as Booster dose which are related to areas like Reactogenicity, Viral Vaccine and Immunogenicity.
His Vaccine efficacy research also works with subjects such as
- Clinical research, which have a strong connection to Viral load and Cohort,
- Clinical endpoint which connect with Regimen, Premature birth, Licensure, Public health and Immunization,
- Interim analysis and related Conjugate vaccine.
His Group B research is multidisciplinary, incorporating perspectives in Case fatality rate, Incidence and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
